<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>JNC 7 Guidelines & Patient Evaluation</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hypertension-introduction.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 4</span>
                    </div>
                    <a href="hypertension-drug-therapy.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">JNC 7 Guidelines & Patient Evaluation</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: section-jnc7-rationale -->
                <section id="section-jnc7-rationale" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Rationale for the JNC 7 Guidelines</span>
                    </h2>
                    <div class="content-card">
                        <p>The 7th Joint National Committee on Hypertension (JNC 7) was established due to the:</p>
                        <ol>
                            <li>publication of many new hypertension observational studies and clinical trials</li>
                            <li>need for a new, clear, and concise guideline that would be useful for clinicians</li>
                            <li>need to simplify the classification of blood pressure</li>
                            <li>clear recognition that the JNC reports were not being used to their maximum benefit</li>
                        </ol>
                    </div>
                </section>
                <!-- END: section-jnc7-rationale -->

                <!-- START: section-benefits -->
                <section id="section-benefits" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Benefits of Lowering Blood Pressure</span>
                    </h2>
                    <div class="content-card">
                        <p>Antihypertensive therapy has been associated with reductions in:</p>
                        <ul>
                            <li>stroke incidence by 35-40%</li>
                            <li>myocardial infarction 20-25%</li>
                        </ul>
                        <p>Goal blood pressure treatment in hypertension is BP below 140/90 mmHg or below 130/80 mmHg for patients with diabetes or chronic kidney disease.</p>
                        <p>In the majority of patients, controlling systolic hypertension has been considerably more difficult than controlling diastolic hypertension. Systolic hypertension is a more important CVD risk factor than DBP except in patients younger than age 50 years. It also occurs much more commonly in older persons.</p>
                        <p>Effective BP control can be achieved in most patients who are hypertensive, but the majority will require two or more antihypertensive drugs.</p>
                        <h4 class="subsubsection-heading">Challenges in BP control</h4>
                        <ul>
                            <li>Patient compliance to drug intake</li>
                            <li>clinicians fail to prescribe lifestyle modifications</li>
                            <li>Inappropriate antihypertensive drug doses</li>
                            <li>Inappropriate antihypertensive drug combinations</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-benefits -->

                <!-- START: section-measurement -->
                <section id="section-measurement" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Accurate Blood Pressure Measurement</span>
                    </h2>
                    <div class="content-card">
                        <p>The auscultatory method of BP measurement with a properly calibrated and validated instrument should be used. Key considerations include:</p>
                        <ul>
                            <li>Persons should be seated quietly for at least 5 minutes in a chair (rather than on an exam table), with feet on the floor, and arm supported at heart level.</li>
                            <li>Measurement of BP in the standing position is indicated periodically, especially in those at risk for postural hypotension.</li>
                            <li>An appropriate-sized cuff (cuff bladder encircling at least 80 percent of the arm) should be used to ensure accuracy.</li>
                            <li>At least two measurements should be made. SBP is the point at which the first of two or more sounds is heard phase 1), and DBP is the point before the disappearance of sounds (phase 5).</li>
                            <li>Clinicians should provide to patients, verbally and in writing, their specific BP numbers and BP goals.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-measurement -->
                
                <!-- START: section-patient-evaluation -->
                <section id="section-patient-evaluation" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Patient Evaluation</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">History and Risk Factor Assessment</h3>
                        <p>The patient history aims to assess lifestyle and identify cardiovascular risk factors.</p>
                        
                        <h4 class="subsubsection-heading">Major risk factors</h4>
                        <strong>Modifiable</strong>
                        <ul>
                            <li>✓ Hypertension</li>
                            <li>✓ Cigarette smoking</li>
                            <li>✓ Hyperlipidaemia</li>
                            <li>✓ Diabetes mellitus</li>
                        </ul>
                        <strong>Non-modifiable factors</strong>
                        <ul>
                            <li>✓ Age (older than 55 for men, 65 for women)</li>
                            <li>✓ Family history of premature cardiovascular disease(men under age 55 or women under age 65)</li>
                            <li>✓ Male gender</li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Minor risk factors</h4>
                        <ul>
                            <li>✓ Obesity* (body mass index ≥30 kg/m<sub>2</sub>)</li>
                            <li>✓ Physical inactivity</li>
                            <li>✓ Microalbuminuria or estimated GFR <60 mL/min</li>
                            <li>✓ Stress type A personality</li>
                            <li>✓ Low HDL</li>
                            <li>✓ Post menopausal estrogen deficiency</li>
                        </ul>

                        <h3 class="subsection-heading">Physical Examination</h3>
                        <ul>
                            <li>Appropriate measurement of BP, with verification in the contralateral arm</li>
                            <li>Examination of the optic fundi</li>
                            <li>Calculation of body mass index(BMI) (measurement of waist circumference also may be useful)</li>
                            <li>Auscultation for carotid, abdominal, and femoral bruits</li>
                            <li>Palpation of the thyroid gland</li>
                            <li>Thorough examination of the heart and lungs;</li>
                            <li>Examination of the abdomen for enlarged kidneys, masses, and abnormal aortic pulsation</li>
                            <li>Palpation of the lower extremities for edema and pulses; and neurological assessment.</li>
                        </ul>
                        
                        <h3 class="subsection-heading">Laboratory and Optional Tests</h3>
                        <p>Optional tests include measurement of urinary albumin excretion or albumin/creatinine ratio. Other tests may be done to diagnose the etiology of secondary hypertension.</p>
                    </div>
                </section>
                <!-- END: section-patient-evaluation -->

                <!-- START: section-goals -->
                <section id="section-goals" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Goals of Therapy</span>
                    </h2>
                    <div class="content-card">
                        <p>The ultimate public health goal of antihypertensive therapy is the reduction of cardiovascular and renal morbidity and mortality. Since most persons with hypertension, especially those age >50 years, will reach the DBP goal once SBP is at goal, the primary focus should be on achieving the SBP goal.</p>
                        <p>Treating SBP and DBP to targets that are <140/90 mmHg is associated with a decrease in CVD complications.</p>
                        <p>In patients with hypertension and diabetes or renal disease the BP goal is <130/80 mmHg.</p>
                    </div>
                </section>
                <!-- END: section-goals -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="hypertension-introduction.html" class="nav-button"> 
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 4</span>
                    </div>
                    <a href="hypertension-drug-therapy.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>